Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1586, 2007-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
BNP-guided HF therapy does not improve outcomes in elderly
Inpharma, Vol. 1, Iss. 1654, 2008-01 ,pp. :
Access to resources
Recommend
Oxaliplatin plus irinotecan seems highly promising as a first-line treatment option
Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. :
Appropriate diagnosis appears to improve therapy in CHF
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 482, 2005-01 ,pp. :
Tolvaptan: advantages over standard therapy in CHF
Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. :
Appropriate diagnosis appears to improve therapy in CHF
Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. :